LA

Lalita Ajitkumar Bhande

Active Director Director DIN 11099673
DIN 11099673 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Lalita Ajitkumar Bhande

Data last updated:

Lalita Ajitkumar Bhande is a Director at Lykos Pharma Private Limited (since 2025).

DIN 11099673
Primary Designation Director
First Appointment 09 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lykos Pharma Private Limited U46497PN2025PTC241807
Director09 May 20252025Active

Board colleagues of Lalita Ajitkumar Bhande

NameDINCompanyDesignation
Rahul Ajitkumar Bhande08391545Lykos Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lykos Pharma Private Limited
Premium access

Shareholding and investment profile for Lalita Ajitkumar Bhande

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalita Ajitkumar Bhande

Lalita Ajitkumar Bhande currently holds 1 directorship: Lykos Pharma Private Limited (Director, since 09 May 2025).

Lalita Ajitkumar Bhande was first appointed on 09 May 2025 as Director at Lykos Pharma Private Limited.

The current boards of Lalita Ajitkumar Bhande's companies include Rahul Ajitkumar Bhande (Lykos Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available